Full Text
Cost-Analysis for Toxicity Management in Advanced Squamous Non-Small Cell Lung Cancer- Nivolumab vs Docetaxel

Abstract

Authors

N Ortega-Joaquin M Echave I Oyagüez P Garrido E Felip J Trigo M Filori P González García

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×